8,024 companies listed on NYSE, Nasdaq and the OTC markets. Financials come straight from their SEC filings.
Prices as of the close on Oct 19, 2026
How Healthcare stocks moved on Oct 19, 2026
1,208 companies
| Revenue |
|---|
| Net margin |
|---|
| P/E |
|---|
| 201 | $40.37 | +0.60% | +12.11% | +14.30% | $2.07B | $306.30M | 7.9% | 85.3 | ||
| 202 | $8.07 | +3.59% | +3.46% | +21.72% | $2.06B | $940.61M | −40.9% | – | ||
| 203 | $70.15 | +1.98% | −23.94% | −10.08% | $2.03B | $898.74M | 15.0% | 15.0 | ||
| 204 | $10.95 | +6.21% | +39.49% | +18.51% | $2.00B | $335.41M | −5.1% | – | ||
| 205 | $7.47 | +3.03% | +96.58% | +252.4% | $1.99B | $112.15M | −66.7% | – | ||
| 206 | $10.28 | +2.70% | +18.30% | +33.85% | $1.98B | $1.14B | – | – | ||
| 207 | $66.29 | +4.21% | −49.03% | −45.19% | $1.98B | $454.43M | −23.4% | – | ||
| 208 | $3.61 | +4.18% | −11.74% | −38.40% | $1.93B | $54.86M | −945.9% | – | ||
| 209 | $14.71 | +0.68% | −4.79% | −28.56% | $1.93B | $3.37B | −2.6% | – | ||
| 210 | $16.77 | +1.82% | −21.93% | +7.02% | $1.90B | $4.02M | – | – | ||
| 211 | $35.24 | +1.79% | +7.67% | +112.4% | $1.89B | $251.17M | −13.4% | – | ||
| 212 | $82.31 | +1.84% | +1.49% | −4.95% | $1.88B | $262.43M | 25.0% | 28.7 | ||
| 213 | $17.73 | +3.68% | −17.61% | −21.24% | $1.87B | $1.97B | −6.9% | – | ||
| 214 | $20.92 | +3.05% | −42.35% | −51.97% | $1.85B | – | – | – | ||
| 215 | $26.30 | +4.03% | – | – | $1.83B | – | – | – | ||
| 216 | $6.99 | +2.95% | +115.1% | +111.8% | $1.82B | $208.78M | −37.1% | – | ||
| 217 | $25.54 | +2.04% | −3.00% | +38.80% | $1.81B | $37.13M | −404.0% | – | ||
| 218 | nvaxNovavax | $10.82 | −3.91% | +61.01% | +33.58% | $1.78B | $413.80M | −59.9% | – | |
| 219 | $122.96 | +2.21% | +17.47% | +68.09% | $1.77B | – | – | – | ||
| 220 | $29.37 | +7.82% | +10.75% | +19.34% | $1.75B | $106.73M | −140.4% | – | ||
| 221 | $26.71 | +7.53% | −26.44% | +11.52% | $1.74B | $10.00M | – | – | ||
| 222 | $58.26 | −1.55% | −20.06% | +23.26% | $1.74B | $245.82M | −15.8% | – | ||
| 223 | $14.89 | +5.83% | +15.16% | +8.06% | $1.73B | $699.19M | −21.2% | – | ||
| 224 | $23.12 | +2.30% | +29.31% | +19.73% | $1.73B | $259.04M | −21.0% | – | ||
| 225 | $10.21 | +2.51% | +69.32% | +76.64% | $1.73B | $303.23M | −83.0% | – | ||
| 226 | $23.19 | +1.49% | +51.47% | +57.01% | $1.72B | $104.97M | −155.6% | – | ||
| 227 | $11.35 | +5.29% | +0.53% | −28.84% | $1.71B | – | – | – | ||
| 228 | $36.38 | +0.08% | +30.49% | +64.91% | $1.70B | $98.88M | −24.5% | – | ||
| 229 | $15.88 | +1.47% | +99.50% | +73.93% | $1.70B | $69.67M | −153.8% | – | ||
| 230 | $11.90 | +0.17% | −4.95% | +14.86% | $1.70B | – | – | – | ||
| 231 | $8.42 | −1.75% | −26.33% | −32.69% | $1.68B | $3.64B | −15.0% | – | ||
| 232 | $34.15 | −1.19% | +45.82% | +101.5% | $1.67B | $188.73M | −51.7% | – | ||
| 233 | $72.56 | +0.37% | −8.08% | −23.45% | $1.67B | $978.38M | 11.1% | 15.4 | ||
| 234 | $29.70 | +7.88% | −28.31% | +6.80% | $1.65B | $167.50M | −79.8% | – | ||
| 235 | $11.69 | −2.18% | +32.39% | −20.10% | $1.65B | $6.41B | 1.2% | 21.1 | ||
| 236 | $34.03 | −3.57% | +4.35% | +30.28% | $1.64B | $525.97M | −23.3% | – | ||
| 237 | $11.58 | +1.40% | +28.81% | −53.21% | $1.62B | $59.51M | −672.2% | – | ||
| 238 | genbGenerate Biomedicines | $12.56 | +3.89% | – | – | $1.61B | – | – | – | |
| 239 | $10.41 | −0.48% | −50.52% | −30.09% | $1.61B | $815.05M | −13.5% | – | ||
| 240 | $24.82 | +2.69% | −21.80% | −25.98% | $1.60B | $27.59M | −753.6% | – | ||
| 241 | $39.34 | +1.34% | +5.30% | −0.96% | $1.60B | $1.52B | 6.6% | 16.0 | ||
| 242 | $22.20 | +1.93% | −7.23% | −61.72% | $1.54B | $18.67M | – | – | ||
| 243 | $11.11 | +3.35% | +61.01% | +70.40% | $1.54B | – | – | – | ||
| 244 | $29.84 | +1.50% | −14.03% | −11.08% | $1.54B | $430.78M | −4.2% | – | ||
| 245 | $21.08 | +1.44% | +5.45% | +22.06% | $1.52B | $440.00M | – | – | ||
| 246 | $32.09 | +6.72% | – | – | $1.50B | – | – | – | ||
| 247 | $88.83 | +4.36% | +415.9% | +270.2% | $1.49B | $5.92B | −3.9% | – | ||
| 248 | $15.07 | +3.65% | −34.48% | −53.82% | $1.49B | $717.21M | −81.7% | – | ||
| 249 | $11.43 | +1.60% | – | – | $1.48B | – | – | – | ||
| 250 | $49.24 | +5.64% | +52.35% | +113.3% | $1.47B | $237.61M | 82.4% | 7.5 |